# Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients

> **NCT03321188** · PHASE2 · UNKNOWN · sponsor: **Andrea Jewell** · enrollment: 20 (estimated)

## Conditions studied

- Ovarian Cancer
- Epithelial Ovarian Cancer
- Fallopian Tube Cancer

## Interventions

- **PROCEDURE:** HIPEC
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT03321188
- **Lead sponsor:** Andrea Jewell
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-15
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321188, "Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03321188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*